Norway · Delayed Price · Currency is NOK Lytix Biopharma AS Statistics
Total Valuation
OSL:LYTIX has a market cap or net worth of NOK 693.81 million. The enterprise value is 623.66 million.
| Market Cap | 693.81M |
| Enterprise Value | 623.66M |
Important Dates
The last earnings date was Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OSL:LYTIX has 75.09 million shares outstanding. The number of shares has increased by 26.05% in one year.
| Current Share Class | 75.09M |
| Shares Outstanding | 75.09M |
| Shares Change (YoY) | +26.05% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.82% |
| Owned by Institutions (%) | 15.86% |
| Float | 37.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 11.24 |
| P/TBV Ratio | 11.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.40 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.28, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.28 |
| Quick Ratio | 4.28 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -303.45 |
Financial Efficiency
Return on equity (ROE) is -70.72% and return on invested capital (ROIC) is -45.87%.
| Return on Equity (ROE) | -70.72% |
| Return on Assets (ROA) | -35.09% |
| Return on Invested Capital (ROIC) | -45.87% |
| Return on Capital Employed (ROCE) | -101.68% |
| Weighted Average Cost of Capital (WACC) | 1.76% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -7.50M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +81.18% in the last 52 weeks. The beta is -0.46, so OSL:LYTIX's price volatility has been lower than the market average.
| Beta (5Y) | -0.46 |
| 52-Week Price Change | +81.18% |
| 50-Day Moving Average | 9.45 |
| 200-Day Moving Average | 8.84 |
| Relative Strength Index (RSI) | 46.99 |
| Average Volume (20 Days) | 65,050 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -64.03M |
| Pretax Income | -59.98M |
| Net Income | -59.98M |
| EBITDA | -63.99M |
| EBIT | -64.03M |
| Earnings Per Share (EPS) | -0.88 |
Balance Sheet
The company has 72.36 million in cash and 2.20 million in debt, with a net cash position of 70.16 million or 0.93 per share.
| Cash & Cash Equivalents | 72.36M |
| Total Debt | 2.20M |
| Net Cash | 70.16M |
| Net Cash Per Share | 0.93 |
| Equity (Book Value) | 61.75M |
| Book Value Per Share | 0.90 |
| Working Capital | 60.88M |
Cash Flow
| Operating Cash Flow | -59.85M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OSL:LYTIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.05% |
| Shareholder Yield | -26.05% |
| Earnings Yield | -8.65% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |